Aid cuts have shaken HIV care and threaten millions more infections

Lead: In 2025 sweeping reductions in overseas health aid — led by abrupt US cuts and mirrored by the UK and other European donors — have disrupted HIV services across multiple countries in sub‑Saharan Africa. Clinics and community programmes that once delivered prevention, testing and community support were closed or curtailed, leaving people without services when they needed them. UNAIDS now warns that, without quick restoration and domestic scale‑up, there could be 3.3 million additional new HIV infections by 2030. On-the-ground reports already describe stockouts, shorter medication supplies and rising AIDS deaths in some countries.

Key takeaways

• External health assistance in 2025 is estimated to be 30–40% below 2023 levels, after abrupt US cuts in January and subsequent reductions from other donors.
• UNAIDS projects up to 3.3 million additional new HIV infections by 2030 if services are not restored and scaled up.
• Prevention programmes were hit hardest; in Burundi, use of preventive HIV medicines fell by 64% after donor support declined.
• Service interruptions include clinic closures (Mozambique), stockouts of test kits (Ethiopia, DRC) and curtailed dispensing of antiretrovirals (e.g., one Lualaba patient given 30 days’ supply instead of 90).
• Aids‑related deaths have increased in Zimbabwe for the first time in five years, signaling early negative trends in some settings.
• Key population and community‑led services have disproportionately closed, reducing safe access for men who have sex with men, sex workers, people who inject drugs, transgender people and prisoners.
• Some governments (Nigeria, Uganda, Côte d’Ivoire, South Africa, Tanzania) have pledged to raise domestic HIV funding, and new prevention tools such as long‑acting injectables are gaining traction.

Background

Over the first month of 2025 the US administration suspended large portions of overseas development assistance; partial restorations followed but funding flows remain substantially lower than in 2023. The shortfall has affected not only national programmes but the dense web of international NGOs and community groups that specialise in prevention, community outreach and stigma‑sensitive care. Many of those interventions were financed primarily by donors and had not been fully transitioned to domestic budgets.

For a decade, global HIV response strategies combined scaled antiretroviral treatment with targeted prevention for higher‑risk groups and age cohorts, such as adolescent girls and young women in sub‑Saharan Africa. Donor support enabled community‑led clinics, mobile testing units and comprehensive prevention packages. When those external funds shrink abruptly, preventive services — which are often more donor‑dependent than routine treatment — are the first to be reduced.

Main event

Field reports released in late 2025 describe closed clinics and interrupted outreach in multiple countries. In Mozambique a teenage rape survivor arrived at a health unit to seek HIV care and emergency prevention but found the clinic closed. In Ethiopia and the Democratic Republic of the Congo, health workers reported running out of HIV test kits, leaving people with suspected infection undiagnosed and unlinked to care.

In Lualaba province a person living with HIV received only a 30‑day antiretroviral supply instead of the standard 90 days, attributed to USAID funding reductions that constrained medicine procurement and distribution. Meanwhile in Zimbabwe official statistics show AIDS‑related deaths rising for the first time in five years, an early indicator that the prior downward trajectory may be reversing where services are weakened.

Charity‑led country reviews by Frontline Aids covering Angola, Kenya, Malawi, Mozambique, Nigeria, Tanzania, Uganda and Zimbabwe corroborate many of the same problems: closures of targeted services, diminished community outreach and gaps in prevention for adolescent girls and young women. Frontline Aids and other field actors report that some clients now conceal membership in key populations in order to access care at public clinics, risking loss of vital surveillance data about transmission patterns.

Analysis & implications

The immediate effect of the funding shock is logistical: fewer test kits, outreach workers and harm‑reduction programmes. But the medium‑term consequence is epidemiological. Prevention programmes interrupting services can increase population‑level incidence because infections that would have been averted now occur, and each new infection raises the baseline for future spread. UNAIDS’s modelling warning of 3.3 million extra infections by 2030 reflects this compounding dynamic.

Disruptions also concentrate harm. When community‑led and stigma‑sensitive services close, members of key populations lose safe points of access and may disengage from care. That raises both individual risk and broader public‑health risk because untreated individuals have higher viral loads and greater transmission potential. The disproportionate effect on adolescent girls and young women in parts of sub‑Saharan Africa could reverse recent declines in that group’s incidence.

There are economic and policy implications as well. Countries forced to substitute domestic funding may reallocate finite health budgets, creating trade‑offs with other priorities. Donor volatility undermines longer‑term planning and investments in innovations (like long‑acting injectables) that require stable procurement and delivery channels. Conversely, the crisis has spurred some governments and communities to explore more sustainable, homegrown financing models and to pilot integration of HIV services into broader primary care to reduce donor dependence.

Comparison & data

The table summarises headline figures reported by international agencies and country reviews. While some metrics (like short‑term service interruptions) are measurable immediately, full epidemiological impact will be visible only over several years as modelling and surveillance data are updated. Local variability is large: some countries report new domestic funding pledges that may blunt projected increases.

Reactions & quotes

“The complex ecosystem that sustains HIV services in dozens of low‑ and middle‑income countries was shaken to its core,” said Winnie Byanyima, urging political commitment to restore and protect services.

Winnie Byanyima / UNAIDS (executive director)

“We are already seeing progress slip backwards,” said John Plastow, noting both the damage and early moves toward locally owned responses in some settings.

John Plastow / Frontline Aids (executive director)

Community members interviewed in country reviews described the loss of safe, stigma‑free clinics as leading to isolation and worsened mental health, particularly among LGBTQ+ people and young women who relied on targeted services.

Frontline Aids country reports (charity field research)

Unconfirmed

• Precise national counts of clinic closures across all affected countries remain incomplete and are still being compiled by NGOs and ministries.
• Long‑term effects on incidence in each country will depend on domestic budget responses and are therefore model projections, not certainties.
• Some local reports of service disruption are anecdotal and await validation through national surveillance or donor accounting.

Bottom line

The 2025 donor funding shock has exposed vulnerabilities in the global HIV response: prevention activities and community‑led services were especially reliant on external funds and are now the first casualties. Early signals — stockouts, shorter ARV dispensing, rising AIDS deaths in limited settings — align with the modelling that projects millions more infections by 2030 if gaps persist.

Mitigation will require a combination of urgent donor reengagement, accelerated domestic financing, targeted protection for community and key‑population services, and investment in resilient delivery systems for new tools such as long‑acting injectables. Political choices in the next 12–24 months will materially shape whether recent gains against HIV are consolidated or lost.

Sources

• The Guardian — media reporting and synthesis of field accounts (news)
• UNAIDS — UN agency reporting and modelling on HIV projections (official)
• Frontline Aids — charity country reports covering Angola, Kenya, Malawi, Mozambique, Nigeria, Tanzania, Uganda and Zimbabwe (NGO/field research)
• USAID — US government agency and primary funder referenced in field accounts (official)
• The Washington Post — photographic reporting cited in field coverage (media)